To Örebro University

oru.seÖrebro University Publications
Change search
Link to record
Permanent link

Direct link
Publications (10 of 17) Show all publications
Hildén, K., Simmons, D., Hanson, U., Montgomery, S., Magnuson, A., Schwarcz, E. & Backman, H. (2024). Author reply [Letter to the editor]. British Journal of Obstetrics and Gynecology
Open this publication in new window or tab >>Author reply
Show others...
2024 (English)In: British Journal of Obstetrics and Gynecology, ISSN 1470-0328, E-ISSN 1471-0528Article in journal, Letter (Other academic) Epub ahead of print
Place, publisher, year, edition, pages
Wiley-Blackwell Publishing Inc., 2024
National Category
Obstetrics, Gynecology and Reproductive Medicine Endocrinology and Diabetes
Identifiers
urn:nbn:se:oru:diva-112405 (URN)10.1111/1471-0528.17806 (DOI)001183574600001 ()38472158 (PubMedID)
Available from: 2024-03-19 Created: 2024-03-19 Last updated: 2024-03-25Bibliographically approved
de Brun, M., Magnuson, A., Montgomery, S., Patil, S., Simmons, D., Berntorp, K., . . . Backman, H. (2024). Changing diagnostic criteria for gestational diabetes (CDC4G) in Sweden: A stepped wedge cluster randomised trial. PLoS Medicine, 21(7), Article ID e1004420.
Open this publication in new window or tab >>Changing diagnostic criteria for gestational diabetes (CDC4G) in Sweden: A stepped wedge cluster randomised trial
Show others...
2024 (English)In: PLoS Medicine, ISSN 1549-1277, E-ISSN 1549-1676, Vol. 21, no 7, article id e1004420Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: The World Health Organisation (WHO) 2013 diagnostic criteria for gestational diabetes mellitus (GDM) has been criticised due to the limited evidence of benefits on pregnancy outcomes in different populations when switching from previously higher glycemic thresholds to the lower WHO-2013 diagnostic criteria. The aim of this study was to determine whether the switch from previous Swedish (SWE-GDM) to the WHO-2013 GDM criteria in Sweden following risk factor-based screening improves pregnancy outcomes.

METHODS AND FINDINGS: A stepped wedge cluster randomised trial was performed between January 1 and December 31, 2018 in 11 clusters (17 delivery units) across Sweden, including all pregnancies under care and excluding preexisting diabetes, gastric bypass surgery, or multifetal pregnancies from the analysis. After implementation of uniform clinical and laboratory guidelines, a number of clusters were randomised to intervention (switch to WHO-2013 GDM criteria) each month from February to November 2018. The primary outcome was large for gestational age (LGA, defined as birth weight >90th percentile). Other secondary and prespecified outcomes included maternal and neonatal birth complications. Primary analysis was by modified intention to treat (mITT), excluding 3 clusters that were randomised before study start but were unable to implement the intervention. Prespecified subgroup analysis was undertaken among those discordant for the definition of GDM. Multilevel mixed regression models were used to compare outcome LGA between WHO-2013 and SWE-GDM groups adjusted for clusters, time periods, and potential confounders. Multiple imputation was used for missing potential confounding variables. In the mITT analysis, 47 080 pregnancies were included with 6 882 (14.6%) oral glucose tolerance tests (OGTTs) performed. The GDM prevalence increased from 595/22 797 (2.6%) to 1 591/24 283 (6.6%) after the intervention. In the mITT population, the switch was associated with no change in primary outcome LGA (2 790/24 209 (11.5%) versus 2 584/22 707 (11.4%)) producing an adjusted risk ratio (aRR) of 0.97 (95% confidence interval 0.91 to 1.02, p = 0.26). In the subgroup, the prevalence of LGA was 273/956 (28.8%) before and 278/1 239 (22.5%) after the switch, aRR 0.87 (95% CI 0.75 to 1.01, p = 0.076). No serious events were reported. Potential limitations of this trial are mainly due to the trial design, including failure to adhere to guidelines within and between the clusters and influences of unidentified temporal variations.

CONCLUSIONS: In this study, implementing the WHO-2013 criteria in Sweden with risk factor-based screening did not significantly reduce LGA prevalence defined as birth weight >90th percentile, in the total population, or in the subgroup discordant for the definition of GDM. Future studies are needed to evaluate the effects of treating different glucose thresholds during pregnancy in different populations, with different screening strategies and clinical management guidelines, to optimise women's and children's health in the short and long term.

TRIAL REGISTRATION: The trial is registered with ISRCTN (41918550).

Place, publisher, year, edition, pages
Public Library of Science (PLoS), 2024
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
urn:nbn:se:oru:diva-114706 (URN)10.1371/journal.pmed.1004420 (DOI)38976676 (PubMedID)
Funder
Swedish Research Council, 2018-00470Region Örebro County, OLL-930268; OLL-693551; OLL-786911Nyckelfonden, OLL-597601Mary von Sydow Foundation, 1017, 4917; 2618; 3718Region StockholmRegion Västmanland, LTV-966501Region Skåne, REGSKANE-622891
Note

Funding: Swedish Research Council (https://www.vr.se/english.html) HB, 2018-00470 ALF Funding Region Örebro County (HB) OLL-930268 The Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement , (VS), GBG-823211, ALFGBG-932692 Nyckelfonden,Region Örebro County, HB), OLL-597601 Region Örebro County Research committee (HB), OLL-693551, OLL-786911 Regional Research committee Uppsala-Örebro (HB), RFR-749241 Stiftelsen Mary von Sydows, född Wijk, donation fund, (VS), numbers 1017, 4917, 2618, and 3718) Clinical therapy research, Region Stockholm County, The Centre of Clinical Research, (ESL), Västmanland County Council, (MdB), LTV-966501 Research Funds of Skåne University Hospital and the Skåne County Council Research and Development Foundation (KB), REGSKANE-622891.

Available from: 2024-07-09 Created: 2024-07-09 Last updated: 2024-07-09Bibliographically approved
Fadl, H., Saeedi, M., Magnuson, A., Patil, S., Simmons, D., Schwarcz, E., . . . Montgomery, S. (2023). Changing diagnostic criteria for gestational diabetes (CDC4G) in Sweden: a stepped wedge cluster randomised controlled trial. In: : . Paper presented at 55th DPSG annual meeting 2023, Poznan, Polen, 7-10 September, 2023.. (1)
Open this publication in new window or tab >>Changing diagnostic criteria for gestational diabetes (CDC4G) in Sweden: a stepped wedge cluster randomised controlled trial
Show others...
2023 (English)Conference paper, Oral presentation only (Other academic)
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:oru:diva-109825 (URN)
Conference
55th DPSG annual meeting 2023, Poznan, Polen, 7-10 September, 2023.
Available from: 2023-11-22 Created: 2023-11-22 Last updated: 2024-01-02Bibliographically approved
Valgeirsdóttir, I. R., Hildén, K., Patil, S., Simmons, D., Schwarcz, E., de Brun, M., . . . Backman, H. (2023). Metformin as treatment of GDM. In: : . Paper presented at Diabetes Pregnancy Study Group (DPSG) Meeting 2023, Poznan, Poland, September 7-9, 2023..
Open this publication in new window or tab >>Metformin as treatment of GDM
Show others...
2023 (English)Conference paper, Poster (with or without abstract) (Other academic)
Abstract [en]

Background: Whether metformin should be used as treatment for gestational diabetes mellitus (GDM) is a matter of controversy. Concerns about the effects on neonatal birth weight (mainly small for gestational age, SGA) have been raised in one randomized controlled trial in type 2 diabetes in pregnancy. [1] The aim of this study was to evaluate pregnancy outcomes based on different GDM treatment modalities with focus on metformin.

Methods: A cohort study, based on data from the stepped wedge cluster randomized trial; CDC4G (Changing diagnostic criteria for GDM in Sweden - www.cdc4g.se). Screening for GDM involved repeated random plasma glucose measurements and/or clinical risk factors. [2] Data were collected from electronic case record forms, and national health and quality registers. Singleton pregnancies during 2018 (last birth in August 2019) from eight clusters were included. Women with pregestational diabetes and/or previous gastric bypass surgery were excluded. Pregnancy outcomes for different treatment regimens were analyzed for women with GDM compared to the background population without GDM. Logistic regression analyzes with adjustments for confounders (body mass index, age, smoking, country of birth, chronic hypertensive disease and cluster) was performed (adjusted odds ratio (aOR) with 95% confidence interval (CI)) for all outcomes. 

Results: Of the 54 678 pregnancies included, 2 169 (4.0%) were diagnosed with GDM; of whom 1 076 (49.6%) were treated with diet only (dGDM), 668 (30.8%) with metformin only (mGDM), 116 (5.3%) with insulin only (iGDM), and 309 (14.2%) with both metformin and insulin (miGDM). Pregnancy outcomes were as follows: SGA (10th percentile) was significantly decreased in the mGDM group [aOR 0.57 (95% CI 0.41-0.79)] compared to the background population and no significant difference was found in the miGDM group [aOR 0.78 (95% CI 0.51-1.18)] compared to the background population. No significant difference in SGA (10th percentile) was found in the dGDM group [aOR 1.02 (CI 0.83-1.25)] compared to the background population. There was significant difference in neonates born large for gestational age (LGA, 90th percentile) in both mGDM and miGDM groups compared to the background population [aOR 2.29 (95% CI 1.88-2.78) and aOR 2.32 (95% CI 1.76-3.07), respectively]. There was not significant difference in LGA (90th percentile) in dGDM compared to the background population [aOR 0.90 (95% CI 0.73-1.12].

Conclusions: These preliminary unpublished results show no increase in SGA for metformin treated GDM compared to the background population. Outcomes in the diet treated GDM group were similar to the background population. Further analyzes are needed to compare outcomes between pharmacologic treatment groups and assess whether specific treatment regimens lead to similar outcomes in different subgroups (eg ethnicity, obesity and glucose values on diagnostic oral glucose tolerance test).

References:

1.Feig DS, Donovan LE, Zinman B, Sanchez JJ, Asztalos E, Ryan EA, et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. The lancet Diabetes & endocrinology. 2020;8(10):834-44.

2.Fadl H, Saeedi M, Montgomery S, Magnuson A, Schwarcz E, Berntorp K, et al. Changing diagnostic criteria for gestational diabetes in Sweden - a stepped wedge national cluster randomised controlled trial - the CDC4G study protocol. BMC pregnancy and childbirth. 2019;19(1):398.

Keywords
Gestational diabetes
National Category
Medical and Health Sciences Obstetrics, Gynecology and Reproductive Medicine Endocrinology and Diabetes
Research subject
Obstetrics and Gynaecology
Identifiers
urn:nbn:se:oru:diva-114096 (URN)
Conference
Diabetes Pregnancy Study Group (DPSG) Meeting 2023, Poznan, Poland, September 7-9, 2023.
Available from: 2024-06-05 Created: 2024-06-05 Last updated: 2024-06-07Bibliographically approved
Hildén, K., Magnuson, A., Montgomery, S., Schwarcz, E., Hanson, U., Simmons, D. & Backman, H. (2023). Previous pre-eclampsia, gestational diabetes mellitus and the risk of cardiovascular disease: A nested case-control study in Sweden. British Journal of Obstetrics and Gynecology, 130(10), 1209-1216
Open this publication in new window or tab >>Previous pre-eclampsia, gestational diabetes mellitus and the risk of cardiovascular disease: A nested case-control study in Sweden
Show others...
2023 (English)In: British Journal of Obstetrics and Gynecology, ISSN 1470-0328, E-ISSN 1471-0528, Vol. 130, no 10, p. 1209-1216Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: Pre-eclampsia and gestational diabetes mellitus (GDM) are two common pregnancy complications that affect birth outcomes and are associated with a long-term risk of cardiovascular disease (CVD). The aims of this study were to investigate if the pre-eclampsia association with CVD is independent of GDM and modified by body mass index (BMI) or GDM. DESIGN: Case-control study.

SETTING: Sweden.

POPULATION: Cases were women with a first CVD event between 1991 and 2008 and a previous pregnancy who were matched with controls without CVD (1:5) by year of birth, age and region of birth. METHODS: Conditional logistic regression was used to evaluate the associations of GDM, pre-eclampsia and maternal BMI with CVD adjusted for potential confounders and effect modifications with interaction tests.

MAIN OUTCOME MEASURES: CVD.

RESULTS: There were 2639 cases and 13 310 controls with complete data. Pre-eclampsia and GDM were independent risk factors for CVD (adjusted odds ratio [aOR] 2.59, 95% CI 2.12-3.17 and aOR 1.47, 95% CI 1.04-2.09, respectively). After stratifying by maternal BMI, the adjusted association of pre-eclampsia with CVD did not differ notably between BMI groups: normal weight (aOR 2.65, 95% CI 1.90-3.69), overweight (aOR 2.67, 95% CI 1.52-4.68) and obesity (aOR 3.03, 95% CI 0.74-12.4). Similar findings were seen when stratifying on GDM/non-GDM.

CONCLUSIONS: Pre-eclampsia and GDM are independent risk factors for later CVD and having both during pregnancy is a major risk factor for later CVD. The association between pre-eclampsia and CVD is not modified by BMI. Effective CVD preventive programs for high-risk women are urgently needed in order to improve women's long-term health.

Place, publisher, year, edition, pages
John Wiley & Sons, 2023
Keywords
Cardiovascular disease, gestational diabetes, hypertension, morbidity, mortality, overweight, pre-eclampsia, pregnancy, smoking
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:oru:diva-105221 (URN)10.1111/1471-0528.17454 (DOI)000959281800001 ()36974033 (PubMedID)2-s2.0-85151416172 (Scopus ID)
Funder
Region Örebro County, OLL 939071 OLL 961321
Available from: 2023-03-30 Created: 2023-03-30 Last updated: 2023-12-08Bibliographically approved
Hildén, K. & Kernell, K. (2021). Avvikande fostervattenmängd (3ed.). In: Gunilla Ajne; Marie Blomberg; Ylva Carlsson (Ed.), Obstetrik: (pp. 381-386). Studentlitteratur AB
Open this publication in new window or tab >>Avvikande fostervattenmängd
2021 (Swedish)In: Obstetrik / [ed] Gunilla Ajne; Marie Blomberg; Ylva Carlsson, Studentlitteratur AB, 2021, 3, p. 381-386Chapter in book (Refereed)
Place, publisher, year, edition, pages
Studentlitteratur AB, 2021 Edition: 3
National Category
Obstetrics, Gynecology and Reproductive Medicine
Identifiers
urn:nbn:se:oru:diva-105856 (URN)9789144142609 (ISBN)
Available from: 2023-05-05 Created: 2023-05-05 Last updated: 2023-05-05Bibliographically approved
Östling, H., Ugarph-Edfeldt, M. & Hildén, K. (2021). Two cases of severe COVID-19 in gestational week 27 and 28 respectively, after which both pregnancies proceeded to term. International journal of obstetric anesthesia, 48, Article ID 103212.
Open this publication in new window or tab >>Two cases of severe COVID-19 in gestational week 27 and 28 respectively, after which both pregnancies proceeded to term
2021 (English)In: International journal of obstetric anesthesia, ISSN 0959-289X, E-ISSN 1532-3374, Vol. 48, article id 103212Article in journal (Refereed) Published
Abstract [en]

COVID-19 in pregnancy increases the risk of caesarean section. We present two cases of late gestation pregnant women with severe COVID-19. Both were successfully treated with mechanical ventilation without termination of pregnancy and, following recovery from COVID-19, had vaginal deliveries at term. These two cases demonstrate the possibility of treating pregnant women with severe COVID-19 with mechanical ventilation in the late second and early third trimesters without them having a pre-term delivery. With a multidisciplinary approach, such management could avoid the maternal risks of surgery during a severe infection and, at the same time, enable term birth with a lower risk of neonatal complications.

Place, publisher, year, edition, pages
Elsevier, 2021
Keywords
COVID-19, Intensive care, Pregnancy, term
National Category
Obstetrics, Gynecology and Reproductive Medicine Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:oru:diva-94376 (URN)10.1016/j.ijoa.2021.103212 (DOI)000706608700006 ()34500190 (PubMedID)2-s2.0-85114308145 (Scopus ID)
Funder
Region Örebro County
Available from: 2021-09-16 Created: 2021-09-16 Last updated: 2022-02-09Bibliographically approved
Stenberg, E., Ruoqing, C., Hildén, K. & Fall, K. (2020). Pregnancy As a Risk Factor for Small Bowel Obstruction After Laparoscopic Gastric Bypass Surgery. Annals of Surgery, 272(1), 125-129
Open this publication in new window or tab >>Pregnancy As a Risk Factor for Small Bowel Obstruction After Laparoscopic Gastric Bypass Surgery
2020 (English)In: Annals of Surgery, ISSN 0003-4932, E-ISSN 1528-1140, Vol. 272, no 1, p. 125-129Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: To evaluate whether pregnancy is associated with increased risk for small bowel obstruction after laparoscopic gastric bypass surgery.

BACKGROUND: Small bowel obstruction is a common and feared long-term complication to laparoscopic gastric bypass surgery that may be more common during pregnancy. It is unclear if the risk truly increases during pregnancy.

METHODS: Women, 18 to 55 years, operated with a primary laparoscopic gastric bypass procedure from 2010 until 2015 were identified through the Scandinavian Obesity Surgery Registry (n = 25,853). Through record-linkage to the Medical Birth Registry, the National Patient Registry, and review of hospital charts, information on pregnancy periods and outcome were obtained. The main outcome was operation due to small bowel obstruction after the laparoscopic gastric bypass procedure.

RESULTS: Pregnancy was associated with increased risk for small bowel obstruction following laparoscopic gastric bypass surgery (incidence rates 46.5, 95% CI 38.0-56.9/1000 person-years, vs 20.9 95% CI 19.9-22.0; adjusted-HR 1.72, 95% CI 1.39-2.12, P < 0.001). While no excess risk was observed during the first trimester, the second (adjusted-HR 1.67, 95% CI 1.17-2.39, P = 0.005) and third (adjusted-HR 2.69, 95% CI 2.02-3.59, P < 0.001) conferred increased risk. The incidence rate of small bowel obstruction during pregnancy was 42.9 (95% CI 32.4-57.0/1000 person-years) among women for whom the mesenteric defects had been closed during the primary procedure, and 53.2 (95% CI 38.9-72.8/1000 person-years) for women in whom they had been left open.

CONCLUSION: Pregnancy is associated with increased risk for small bowel obstruction after laparoscopic gastric bypass surgery during the second and third trimesters.

Place, publisher, year, edition, pages
Lippincott Williams & Wilkins, 2020
Keywords
internal hernia, laparoscopic gastric bypass, postoperative complication, pregnancy, small bowel obstruction, women
National Category
Obstetrics, Gynecology and Reproductive Medicine Surgery
Identifiers
urn:nbn:se:oru:diva-71182 (URN)10.1097/SLA.0000000000003163 (DOI)000568895500036 ()30601250 (PubMedID)2-s2.0-85086766474 (Scopus ID)
Note

Funding Agencies:

Örebro County Council  

Örebro University 

Available from: 2019-01-08 Created: 2019-01-08 Last updated: 2023-06-29Bibliographically approved
Hildén, K., Magnuson, A., Hanson, U., Simmons, D. & Fadl, H. (2020). Trends in pregnancy outcomes for women with gestational diabetes mellitus in Sweden 1998-2012: a nationwide cohort study. Diabetic Medicine, 37(12), 2050-2057
Open this publication in new window or tab >>Trends in pregnancy outcomes for women with gestational diabetes mellitus in Sweden 1998-2012: a nationwide cohort study
Show others...
2020 (English)In: Diabetic Medicine, ISSN 0742-3071, E-ISSN 1464-5491, Vol. 37, no 12, p. 2050-2057Article in journal (Refereed) Published
Abstract [en]

AIM: To assess whether incidence of maternal and neonatal outcomes for women with or without gestational diabetes mellitus (GDM) have changed over time.

METHODS: Population-based cohort study in Sweden including all singleton pregnancies over the period 1998-2012. GDM was diagnosed following Diabetic Pregnancy Study Group 1991 criteria. Poisson regression or negative binomial regression was used to model yearly relative change in numbers of cases and incidence of the outcomes with 95% confidence intervals (CI), and yearly absolute change in birthweight z-score.

RESULTS: The study included 1 455 667 pregnancies. The number of pregnancies increased over time and the overall prevalence of GDM was 1%. For women with GDM there was a significantly decreasing trend in incidence per year for large for gestational age (LGA) (0.986, 95% CI 0.975 to 0.996), birthweight z-score (-0.012, 95% CI -0.017 to -0.007) and birth trauma (0.937, 95% CI 0.907 to 0.968). The trend for small for gestational age (SGA) among women with GDM increased by an OR per year (1.016, 95% CI 1.002 to 1.029). No significant interaction tests for maternal characteristics were found. Trends in outcomes for women without diabetes were similar to those for women with GDM.

CONCLUSIONS: This study shows that there were improvements in pregnancy outcomes for women with GDM between 1998 and 2012, although the incidence of SGA increased. Improvements followed similar trends in the background population. Inequalities in obstetric outcomes between women with GDM and those without have continued unchanged over 15 years, suggesting that new management strategies are required to reduce this gap.

Place, publisher, year, edition, pages
Wiley-Blackwell Publishing Inc., 2020
National Category
Obstetrics, Gynecology and Reproductive Medicine
Identifiers
urn:nbn:se:oru:diva-79938 (URN)10.1111/dme.14266 (DOI)000561648600001 ()32027045 (PubMedID)2-s2.0-85081633439 (Scopus ID)
Note

Funding Agency:

Örebro County Council 

Available from: 2020-02-19 Created: 2020-02-19 Last updated: 2022-02-03Bibliographically approved
Fadl, H., Saeedi, M., Montgomery, S., Magnuson, A., Schwarcz, E., Berntorp, K., . . . Simmons, D. (2019). Changing diagnostic criteria for gestational diabetes in Sweden: a stepped wedge national cluster randomised controlled trial-the CDC4G study protocol. BMC Pregnancy and Childbirth, 19(1), Article ID 398.
Open this publication in new window or tab >>Changing diagnostic criteria for gestational diabetes in Sweden: a stepped wedge national cluster randomised controlled trial-the CDC4G study protocol
Show others...
2019 (English)In: BMC Pregnancy and Childbirth, ISSN 1471-2393, E-ISSN 1471-2393, Vol. 19, no 1, article id 398Article in journal (Refereed) Published
Abstract [en]

Background: The optimal criteria to diagnose gestational diabetes mellitus (GDM) remain contested. The Swedish National Board of Health introduced the 2013 WHO criteria in 2015 as a recommendation for initiation of treatment for hyperglycaemia during pregnancy. With variation in GDM screening and diagnostic practice across the country, it was agreed that the shift to new guidelines should be in a scientific and structured way. The aim of the Changing Diagnostic Criteria for Gestational Diabetes (CDC4G) in Sweden () is to evaluate the clinical and health economic impacts of changing diagnostic criteria for GDM in Sweden and to create a prospective cohort to compare the many long-term outcomes in mother and baby under the old and new diagnostic approaches.

Methods: This is a stepped wedge cluster randomised controlled trial, comparing pregnancy outcomes before and after the switch in GDM criteria across 11 centres in a randomised manner. The trial includes all pregnant women screened for GDM across the participating centres during January-December 2018, approximately two thirds of all pregnancies in Sweden in a year. Women with pre-existing diabetes will be excluded. Data will be collected through the national Swedish Pregnancy register and for follow up studies other health registers will be included.

Discussion: The stepped wedge RCT was chosen to be the best study design for evaluating the shift from old to new diagnostic criteria of GDM in Sweden. The national quality registers provide data on the whole pregnant population and gives a possibility for follow up studies of both mother and child. The health economic analysis from the study will give a solid evidence base for future changes in order to improve immediate pregnancy, as well as long term, outcomes for mother and child.

Place, publisher, year, edition, pages
BMC, 2019
Keywords
Gestational diabetes mellitus, Pregnancy outcomes, Diagnostic criteria, WHO 2013 criteria, Stepped wedge cluster randomised controlled trial, LGA, Health economics, Obesity
National Category
Obstetrics, Gynecology and Reproductive Medicine
Identifiers
urn:nbn:se:oru:diva-77999 (URN)10.1186/s12884-019-2547-5 (DOI)000494447700004 ()31675922 (PubMedID)2-s2.0-85074418210 (Scopus ID)
Funder
Swedish Research Council, 2018-00470
Note

Funding Agencies:

Fru Mary von Sydows, född Wijk, donation fond  1017 4917 2618

Nyckelfonden Region Örebro County  OLL-597601

Region Örebro County Research committee  OLL-693551 OLL-786911

Regional Research committee Uppsala-Örebro  RFR-749241

Available from: 2019-11-22 Created: 2019-11-22 Last updated: 2024-01-02Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-3707-6696

Search in DiVA

Show all publications